.gif)
- Clinical and applied thrombosis-hemostasis
-
影響因子：
1.575
-
I S S N：
1076-0296
-
出 版 社：
Sage Publications
-
出 版 地：
New York
-
出版國家：
United States
-
刊 期：
季刊
-
創(chuàng)刊時(shí)間：
1995
-
語 種：
英文
-
審稿周期：
平均2月
-
中科院分區(qū)：
4
-
投稿命中率：
命中率約50%
-
國外數(shù)據(jù)庫收錄：
IM
-
中國收錄文章數(shù)：
-
5年影響因子：
1.165
-
研究領(lǐng)域：
周圍血管疾病學(xué)
-
官方鏈接：
http://cat.sagepub.com/
-
投稿須知：
http://cat.sagepub.com/
期刊介紹：
Every issue of Clinical and Applied Thrombosis/Hemostasis (CATH) addresses the practical clinical and laboratory issues involved in managing bleeding and clotting disorders, especially those related to thrombosis, hemostasis, and vascular disorders. CATH offers comprehensive coverage of the topics that matter most to your work, including clinical trials, studies on etiology, pathophysiology, diagnosis and treatment of thrombohemorrhagic disorders, assessment of new clinical diagnostic procedures, pharmacological agents, laboratory diagnostic procedures, and patient management plans. CATH continually evaluates new research in areas including essential drugs such as Warfarin, Heparin, low-molecular-weight Heparin, and other emerging drug therapies; the clinical impact on treatment of diseases and conditions such as diabetes, hypertension, pregnancy, hemophilia, and HIV-AIDS; factor defects; platelet disorders; fibrinolytic disorders; DNA/RNA research; and ethnic and population differences in thrombohemorrhagic disorders.
